Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The analysis revealed that participants who received GLP-1RAs experienced consistent and moderate reductions in core binge eating symptoms compared to those who received a placebo or other comparators
Meanwhile, Wegovy is facing tough competition from Eli Lilly's weight-loss therapy Zepbound (tirzepatide), which outperformed its rival in the head-to-head SURMOUNT-5 trial
Contact us if you have any questions
Specifically, semaglutide achieved NASH resolution in up to 59% of patients at the 0.4 mg dosage, while liraglutide showed resolution in 39% of treated individuals compared to merely 9% with placebo
US$ 21.24
US$ 21.74
US$ 21.95
US$ 23.78
US$ 24.78
US$ 23.70
